53.99
前日終値:
$55.63
開ける:
$55.25
24時間の取引高:
2.69M
Relative Volume:
4.02
時価総額:
$2.59B
収益:
$1.36B
当期純損益:
$123.81M
株価収益率:
22.40
EPS:
2.41
ネットキャッシュフロー:
$20.35M
1週間 パフォーマンス:
-27.79%
1か月 パフォーマンス:
-28.93%
6か月 パフォーマンス:
-9.02%
1年 パフォーマンス:
-29.36%
Haemonetics Corp Stock (HAE) Company Profile
HAE を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HAE
Haemonetics Corp
|
53.99 | 3.64B | 1.36B | 123.81M | 20.35M | 2.41 |
![]()
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-09 | アップグレード | Citigroup | Neutral → Buy |
2025-06-26 | 開始されました | Robert W. Baird | Outperform |
2025-02-07 | ダウングレード | BofA Securities | Neutral → Underperform |
2024-12-06 | 開始されました | JP Morgan | Overweight |
2024-11-08 | アップグレード | Raymond James | Outperform → Strong Buy |
2024-09-13 | 開始されました | CL King | Buy |
2024-09-11 | 開始されました | BofA Securities | Neutral |
2024-09-10 | 開始されました | BTIG Research | Buy |
2024-06-12 | アップグレード | Needham | Hold → Buy |
2022-10-13 | 開始されました | Mizuho | Buy |
2022-01-27 | ダウングレード | Needham | Buy → Hold |
2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
2021-08-17 | 再開されました | Raymond James | Outperform |
2021-06-17 | 開始されました | Citigroup | Buy |
2021-05-14 | アップグレード | CJS Securities | Market Perform → Market Outperform |
2021-04-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-04-19 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
2021-02-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2021-01-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2020-11-05 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2020-03-31 | アップグレード | CJS Securities | Market Perform → Market Outperform |
2020-01-10 | 開始されました | Needham | Buy |
2019-08-07 | 繰り返されました | Barrington Research | Outperform |
2019-05-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
2019-05-08 | 繰り返されました | Barrington Research | Outperform |
2018-08-09 | 繰り返されました | Barrington Research | Outperform |
2018-02-07 | 繰り返されました | Barrington Research | Outperform |
2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2017-11-08 | 繰り返されました | Barrington Research | Outperform |
2017-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2017-07-13 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
2017-02-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2016-11-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2016-11-07 | 繰り返されました | The Benchmark Company | Hold |
2016-09-20 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
2016-08-15 | ダウングレード | Sidoti | Buy → Neutral |
2016-08-02 | 繰り返されました | Jefferies | Buy |
2016-08-02 | 繰り返されました | The Benchmark Company | Hold |
すべてを表示
Haemonetics Corp (HAE) 最新ニュース
Haemonetics’ (HAE) “Neutral” Rating Reiterated at JPMorgan Chase & Co. - Defense World
Mizuho Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - Defense World
Haemonetics Corporation stock outlook for YEARWealth Accumulation Outlook for Safe Investors - Newser
Barrington Research Lowers Haemonetics (NYSE:HAE) Price Target to $86.00 - Defense World
Haemonetics’ (HAE) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $62 to $86 - 富途牛牛
Detecting price anomalies in Haemonetics Corporation with AIFree Trade Ready Stock Watch for Short Term - Newser
What makes Haemonetics Corporation stock price move sharplyAI Swing Strategy Signal Forecasting System - Newser
Is Haemonetics Corporation meeting your algorithmic filter criteriaEarnings Report Summary with Market Impact - Newser
How to escape a deep drawdown in Haemonetics CorporationBuy Point Strategy with Profit Protection - Newser
Haemonetics Reports Q1 Fiscal 2026 Earnings - The Globe and Mail
Haemonetics Corporation stock trendline breakdownFree Breakout Confirmation With Entry Tracker - Newser
Haemonetics Corp Reports Strong Organic Growth Despite Portfolio Transitions - AInvest
These Analysts Slash Their Forecasts On Haemonetics After Q1 Results - Benzinga
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga
Technical signs of recovery in Haemonetics CorporationSummary of Consistent Growth Stock Picks - Newser
Haemonetics stock rating cut by JPMorgan on mixed results - Investing.com
Haemonetics (NYSE:HAE) Shares Down 22.1% Following Analyst Downgrade - Defense World
Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus
Haemonetics Corp (HAE) Analysts Lower Price Target to $68, Maintain "Buy" Rating - AInvest
Haemonetics: Fiscal Q1 Earnings Snapshot - Norwalk Hour
Analyst Needham Lowers Price Target for Haemonetics (HAE) to $68 - GuruFocus
Haemonetics stock price target lowered to $68 at Needham on competition - Investing.com Canada
Earnings call transcript: Haemonetics beats Q1 2026 earnings, stock drops - Investing.com
Haemonetics Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Haemonetics (HAE) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq
Haemonetics Corporation Reports Earnings Results for the First Quarter Ended June 28, 2025 - MarketScreener
Haemonetics (HAE) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Haemonetics earnings beat by $0.09, revenue topped estimates - Investing.com Canada
Haemonetics (HAE) Q1 Revenue Falls 4% - The Motley Fool
Haemonetics Corp Q1 Fiscal 2026 Earnings: Revenue Surpasses Esti - GuruFocus
Haemonetics' Q1 2025 Earnings: Strategic Resilience and Long-Term Value Amid Plasma Challenges - AInvest
Haemonetics Corporation Q1 Fiscal 2026 Results - TradingView
HAEMONETICS CORP SEC 10-Q Report - TradingView
Haemonetics Q1 FY26 Earnings Released Today: Join Live Conference Call for Full Analysis - Stock Titan
Is Haemonetics Corporation stock entering bullish territoryFree Buy Signal Based on Chart Analysis - Newser
Unlocking Q1 Potential of Haemonetics (HAE): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
What makes Haemonetics Corporation stock attractive to long term investorsCapital Protection Strategy With Risk Analysis - Newser
Brokerages Set Haemonetics Corporation (NYSE:HAE) Price Target at $97.30 - Defense World
Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Why Haemonetics Corporation stock attracts strong analyst attentionCapital Safe Picks with Consistent Gains - Newser
Analyzing net buyer seller activity in Haemonetics CorporationDownside Control Plan With Support Analysis - Newser
Using data models to predict Haemonetics Corporation stock movementAccurate Forecast System with AI Support - Newser
Leading vs lagging indicators on Haemonetics Corporation performanceFree Chart Driven High Reward Trading Setup - Newser
What drives Haemonetics Corporation stock priceCapitalize on market trends with confidence - Jammu Links News
What analysts say about Haemonetics Corporation stockCapitalize on emerging market trends - Jammu Links News
Should you hold or exit Haemonetics Corporation nowFree High Growth Low Risk Stock Selection - Newser
Should I hold or sell Haemonetics Corporation stock in 2025Get timely advice on market trends - Jammu Links News
What is Haemonetics Corporation company’s growth strategyGet daily expert analysis for smarter investing - Jammu Links News
What institutional investors are buying Haemonetics Corporation stockExplosive earning power - Jammu Links News
How hedge fund analytics apply to Haemonetics Corporation stockWeekly Entry Signal Based Forecast Tool - Newser
Haemonetics Corp (HAE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):